2024
DOI: 10.1111/crj.13804
|View full text |Cite
|
Sign up to set email alerts
|

Which Is More Suitable for First‐Line Treatment of Extensive‐Stage Small Cell Lung Cancer, PD‐L1 Inhibitors Versus PD‐1 Inhibitors? A Systematic Review and Network Meta‐Analysis

Wenjing Liu,
Lulin Yu,
Yuqian Feng
et al.

Abstract: BackgroundIn this network meta‐analysis (NMA), the efficiency and safety of PD‐1 inhibitors + chemotherapy and PD‐L1 inhibitors + chemotherapy were compared in the first‐line therapy of patients with extensive‐stage small cell lung cancer (ES‐SCLC).MethodsWe searched research databases, conference abstracts, and trial registries and subsequently chose relevant studies and extracted dates. The NMA was conducted to estimate the efficiency and safety of the PD‐1 inhibitors + chemotherapy and PD‐L1 inhibitors + ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 44 publications
(51 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?